Risk factors for thrombosis in pregnancy

被引:15
作者
Hague, WM [1 ]
Dekker, GA
机构
[1] Univ Adelaide, Womens & Childrens Hosp, Dept Obstet, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Lyell McEwin Hlth Serv, Dept Obstet, Elizabeth Vale, SA 5118, Australia
关键词
thrombosis; pre-eclampsia; maternal mortality; thrombophilia;
D O I
10.1016/S1521-6926(03)00018-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pregnancy is a hypercoagulable state affecting both the coagulation and the fibrinolytic systems. Any exacerbation of the pre-disposing factors for coagulation may well lead to a thrombotic event more often in pregnant women than in the general population. Arterial thrombosis is very rare in pregnancy. Pre-eclampsia may be a risk factor for the development of arterial disease in later life. Venous thromboembolism (VTE) in pregnancy, although still rare, is a major cause of maternal mortality. Risk factors, such as older age, increased weight and emergency Caesarean section, as well as acquired and genetic thrombophilia, often coexist and reinforce each other. Appropriate thromboprophylaxis needs to be considered and applied on an individual basis. Uteroplacental thrombosis provides a common pathophysiological link between various poor pregnancy outcomes, including recurrent miscarriage, stillbirth, placental abruption, fetal growth restriction and pre-eclampsia. Its significance depends on the gestational age. Acquired and genetic thrombophilia may be associated with such conditions, particularly in early-onset disease. More data are required to assess the significance of such thrombophilias in obstetric practice. Any treatment should be in the context of clinical trials.
引用
收藏
页码:197 / 210
页数:14
相关论文
共 44 条
[1]   Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy [J].
Åstedt, B ;
Lindoff, C ;
Lecander, I .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 (05) :431-435
[2]  
Brattström L, 2000, AM J CLIN NUTR, V72, P315
[3]   Safety of withholding heparin in pregnant women with a history of venous thromboembolism. [J].
Brill-Edwards, P ;
Ginsberg, JS ;
Gent, M ;
Hirsh, J ;
Burrows, R ;
Kearon, C ;
Geerts, W ;
Kovacs, M ;
Weitz, JI ;
Robinson, KS ;
Whittom, R ;
Couture, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1439-1444
[4]   A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study [J].
Burrows, RF ;
Gan, ET ;
Gallus, AS ;
Wallace, EM ;
Burrows, EA .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (08) :835-839
[5]   Acute hyperhomocysteinaemia and endothelial dysfunction [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Kooner, JS .
LANCET, 1998, 351 (9095) :36-37
[6]   CEREBRAL STROKES ASSOCIATED WITH PREGNANCY AND PUERPERIUM [J].
CROSS, JN ;
CASTRO, PO ;
JENNETT, WB .
BMJ-BRITISH MEDICAL JOURNAL, 1968, 3 (5612) :214-+
[7]   UNDERLYING DISORDERS ASSOCIATED WITH SEVERE EARLY-ONSET PREECLAMPSIA [J].
DEKKER, GA ;
DEVRIES, JIP ;
DOELITZSCH, PM ;
HUIJGENS, PC ;
VONBLOMBERG, BME ;
JAKOBS, C ;
VANGEIJN, HP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) :1042-1048
[8]  
*DEP HLTH, 2001, 5 DEP HLTH
[9]   A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome [J].
Erkan, D ;
Yazici, Y ;
Peterson, MG ;
Sammaritano, L ;
Lockshin, MD .
RHEUMATOLOGY, 2002, 41 (08) :924-929
[10]   Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. [J].
Gerhardt, A ;
Scharf, RE ;
Beckmann, MW ;
Struve, S ;
Bender, HG ;
Pillny, M ;
Sandmann, W ;
Zotz, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :374-380